Enhancing the QUAlity and Transparency Of health Research
The following guidelines are currently being developed:
We encourage everyone to submit brief details about their reporting guideline under development for inclusion on the EQUATOR website. This will raise awareness about the development of your guideline and help to prevent duplication. To register your reporting guideline under development please complete our brief registration form (Word document).
PRISMA Harms will extend the PRISMA Statement to improve harms reporting in systematic reviews and to encourage a more balanced assessment of the benefits and harms of interventions.
An official extension of the CONSORT 2010 Statement for reporting randomised controlled trials of social and psychological interventions is currently under development. A Delphi process to generate possible reporting standards for the guideline will take place in Fall 2013. Interested stakeholders should contact the project team to get involved in the development and dissemination of the guideline.
The STROBE Group have recently developed a checklist for conference abstracts.
This project aims to produce a set of quality criteria and comparable reporting guidance specifically for common neurological disorders.
Development of a guideline to improve the quality of reporting of Phase IV implementation studies, specifically those with a comparator group.
Development of new guidelines for the reporting of meta-ethnography qualitative evidence syntheses.
Development of a checklist that can be used to report nutrition epidemiology.
Case series make up a large portion of the medical literature. This project aims to develop a checklist and guidance document for authors to improve the quality of reporting case series. The literature search is currently ongoing.
Development of essential reporting items for practice guidelines in health systems to ensure the comprehensive and transparent reporting of such guidelines.
Aim: To develop a reporting guideline for pilot and feasibility studies in preparation for a randomized controlled trial; as an extension to the CONSORT Statement.
The IDEAL (Idea, Development, Exploration, Assessment and Long term follow up) framework (1) allows for the phased and sequential development of a new surgical innovation, optimizing patient safety as the evidence-base builds in a controlled and purposeful manner.
These guidelines aim to improve the completeness of reports and protocols for IDEAL Prospective Development Studies (PDS – phase 2a) and Prospective Exploration Studies (PES – phase 2b).
1. McCulloch P, Altman DG, Campbell WB, et al, for the Balliol Collaboration. No surgical innovation without evaluation: the IDEAL recommendations. Lancet 2009; 374: 1105–12.
This project aims to develop a checklist to establish what information and how it should be presented in updated guidelines.
To develop an extension to the reporting guideline for parallel cluster trials to produce recommended reporting guidelines for stepped wedge cluster randomised controlled trials.
An official extension of the CONSORT 2010 Statement for reporting equity focused randomised controlled trials is currently under development.
An official extension of the SPIRIT 2013 Statement defining standard protocol items for clinical trials in children is currently under development. A Delphi process to generate possible reporting standards for the guideline has taken place in Q2-3 2014. A Consensus meeting was held 15 September 2014.
An official extension of the CONSORT 2010 Statement for reporting randomised controlled trials in children is currently under development. A Delphi process to generate possible reporting standards for the guideline has taken place in 2009-2010. A systematic review of the literature was conducted Q2-3 2014. A Consensus meeting was held 16 September 2014.
An official extension of the PRISMA 2009 Statement defining standard reporting items for systematic review in children is currently under development. A Delphi process to generate possible reporting standards for PRISMA-C will take place in Q2/Q3 of 2015. We invite interested stakeholders to participate in the project by contacting the project team.
An official extension of the PRISMA-P Statement defining standard protocol items for systematic review in children is currently under development. A Delphi process to generate possible reporting standards for PRISMA-PC will take place in Q2/Q3 of 2015. We invite interested stakeholders to participate in the project by contacting the project team.
GATHER defines best practices for documenting studies that report global health estimates. Global health estimates include all quantitative population-level estimates (including global, regional, national, or subnational estimates) of health indicators, including indicators of health status such as estimates of total and cause-specific mortality, incidence and prevalence of diseases and injuries; and indicators of health determinants, including health behaviours and health exposures.
A reference tool for use in conjunction with the 1996 ICH E3 (and subsequent relevant ICH) guidance, for clinical study report authoring. CORE Reference will provide clarity on existing guidance and practical solutions for upholding the principles of responsible clinical trial data sharing, to safeguard the anonymity of clinical trial participants.
The SMARTER statement consists of a 12-item checklist and aims primarily to ensure appropriate reporting of the regimen used, number of women treated, number who had follow-up (outcome) data available, and outcomes by gestational age. Reporting outcomes in a standard manner will ensure that data is available for better synthesis into evidence-based guidelines.
Adapting TIDieR (Template for Intervention Description and Replication) checklist for reporting public health, health systems and social and environmental policy interventions with potential to affect population health which do not fit well within the existing TIDieR framework.
Diagnostic accuracy studies evaluate the ability of a diagnostic test to correctly identify patients as having or not having a particular disease. Readers of diagnostic accuracy study reports use abstracts to decide whether they should look for the full study report and invest time in reading it. This decision requires an informative description of the purpose, methods and results of the study. However, abstracts of diagnostic accuracy studies often insufficiently report such information, making it difficult for readers to appraise the potential for bias and the applicability of the study findings.
Our goal is to develop, disseminate and implement a robust reporting guideline that will help improve the informativeness of abstracts of diagnostic accuracy studies regarding essential items that are needed to evaluate elements of study validity.
The SAGER (Sex and Gender Equity in Research) is a guideline to encourage a more systematic approach to the reporting of sex and gender in research across disciplines, promoted by the EASE gender policy committee.
This guideline is intended as an extension or add-on to other guidelines for specific research designs. It addresses how orthotic interventions should be reported within the context of any given quantitative study design.
Implementation research involves increasing access to health products and strategies that are already available and have been shown to work but remain beyond the reach of many of the people who could benefit from them. It is rooted in the identification of practical problems facing disease control programmes and in finding solutions which improve access to health interventions and lead to better health outcomes. Different research methods may be used depending on the type of problem studied.
Operational research uses an existing resource – the data routinely collected by programmes – to provide ways of improving programme operations and thereby delivering more effective, efficient and equitable care. Implementation and operational research are usually carried out in close collaboration between researchers and disease control programme staff.
This project aims to develop a comprehensive set of reporting guidelines for home visiting that improve and enhance the accuracy of reporting home visiting intervention evaluations. Specifically, the reporting guidelines focus on: (1) reporting effectiveness and efficacy studies, (2) incorporation of study designs endorsed by the Home Visiting Effectiveness of Evidence (HomVEE), and (3) inclusion of more thorough guidelines for reporting home visiting intervention design and implementation data.
This project aims to develop a set of reporting standards for organisational case study research relevant to the UK National Health Service (NHS).
When guideline development is completed and the guideline is published we will remove it from this list and include it in our database of reporting guidelines.
Please do let us know about relevant projects; it will avoid duplication of the process and might also help you to find new collaborators. To register your reporting guideline under development please complete our brief registration form (Word document).
Page last updated on: 5 October 2015
|Diagnostic / prognostic studies||STARD||TRIPOD|
|Quality improvement studies||SQUIRE|
|Animal pre-clinical studies||ARRIVE|
Some reporting guidelines are also available in languages other than English. Find out more in our Translations section.
For information about Library scope and content, identification of reporting guidelines and inclusion/exclusion criteria please visit About the Library.
Visit our Help page for information about searching for reporting guidelines and for general information about using our website.
Our full catalogue of reporting guidelines is available to download as a PDF: Reporting Guideline Catalogue May 2014.